Drug-labels.com

PMS-Nystatin Suspension 100000 Unit/mL: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
100000 UNIT
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - PMS-Nystatin Suspension 100000 Unit/mL

What is pms-NYSTATIN SUSPENSION used for?

pms-NYSTATIN SUSPENSION is chosen by your doctor to:

  • prevent and/or treat fungal infections of the:

    • mouth.
    • esophagus (tube from the mouth to the stomach).
    • intestines.
  • most often treat a fungal infection caused by a certain yeast (Candida).

How does pms-NYSTATIN SUSPENSION work?

pms-NYSTATIN SUSPENSION works by killing the yeast or fungus that has caused your symptoms.

What are the ingredients in pms-NYSTATIN SUSPENSION?

Medicinal ingredient: 100 000 units of nystatin per mL.

Non-medicinal ingredients: alcohol, artificial raspberry flavor, artificial wild cherry flavor, citric acid anhydrous (to adjust pH), dibasic potassium phosphate (to adjust pH), D&C yellow nº 10, FD&C red nº 40, glycerine, methylparaben, microcrystalline cellulose and carboxymethyl cellulose sodium, propylene glycol, propylparaben, purified water and sucrose.

pms-NYSTATIN SUSPENSION comes in the following dosage forms:

Suspension: 100 000 units / mL.

Do not use pms-NYSTATIN SUSPENSION if:

  • You are allergic to nystatin or any of the ingredients in the product.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take pms-NYSTATIN SUSPENSION. Talk about any health conditions or problems you may have, including if you:

  • Are pregnant, think you may be pregnant, or plan to get pregnant.

  • Are breast-feeding or plan to breastfeed.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

How to take pms-NYSTATIN SUSPENSION:

This medicine has been prescribed for you or your child and should not be passed on to others. It may harm them even if their symptoms are the same as yours. Always use this medicine exactly as your doctor has told you.

Usual dose:

Your doctor may prescribe for:

Newborn:

For prevention: Give 1 mL (100 000 units) once per day directly into the mouth using the dropper.

Infants:

For prevention and treatment: Give 1 mL (100 000 units) 4 times per day, dropped into the side of the mouth and swallowed.

Children and adults:

For treatment: Take 1 mL (100 000 units) 4 times per day dropped into the mouth. Hold or swish the suspension throughout the mouth for as long as possible, then gargle and swallow.

Shake the bottle well before use.

If you have a fungal infection of the mouth, tell your doctor if you wear dentures. Special cleaning of the dentures may be required.

Overdose:

If you think you have taken too much pms-NYSTATIN SUSPENSION, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms. Take this leaflet or your medication with you so that the hospital or poison control centre will know what you have taken.

Missed Dose:

If you miss a dose, take the missed dose as soon as possible, unless it is almost time for your next dose. Skip the missed dose if it is almost time for your next regular dose. Do not take two doses at the same time.

What are possible side effects from using pms-NYSTATIN SUSPENSION?

Large doses may produce:

  • diarrhea.
  • nausea.
  • vomiting.
  • stomach troubles such as pain and cramps.
  • these are not all possible side effects

Contact your doctor if:

  • you have a side effect not listed above.
  • the side effect(s) become troublesome.
  • the side effect(s) interfere with daily activity.

Reporting Side Effects

You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information.

3 ways to report:

  • Online at MedEffect;
  • By calling 1-866-234-2345 (toll-free);
  • By completing a Consumer Side Effect Reporting Form and sending it by:
  • Fax to 1-866-678-6789 (toll-free), or
  • Mail to: Canada Vigilance Program

    Health Canada, Postal Locator 1908C Ottawa, ON

K1A 0K9

Postage paid labels and the Consumer Side Effect Reporting Form are available at MedEffect.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store between 15°C and 30°C. Store in a tight, light- resistant container. Protect from freezing.

Keep out of reach and sight of children.

If you want more information about pms-NYSTATIN SUSPENSION:

  • Talk to your healthcare professional.
  • Find the full prescribing information that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website; or by calling 1-888-550-6060.

Pharmascience Inc.

Montréal, Canada

H4P 2T4

www.pharmascience.com

Last Revised: January 27, 2017

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00792667

Revision date stated in the text: January 27, 2017

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for PMS-Nystatin Suspension 100000 Unit/mL

Rx or OTC
Prescription (Rx)?
DIN 00792667
Schedule(s) PRESCRIPTION
Active ingredient(s) Nystatin 100000 UNIT
Dosage form(s) Suspension
Route(s) of administration Oral
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents
      1. A07A Intestinal antiinfectives
        1. A07AA Antibiotics, intestinal
          1. A07AA02 Nystatin
Company PHARMASCIENCE INC
Current status Marketed
Current status date December 31, 1989

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.